Literature DB >> 18456875

Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.

Dimitrios I Zonios1, Judith Falloon, John E Bennett, Pamela A Shaw, Doreen Chaitt, Michael W Baseler, Joseph W Adelsberger, Julia A Metcalf, Michael A Polis, Stephen B Kovacs, Stephen J Kovacs, Joseph A Kovacs, Richard T Davey, H Clifford Lane, Henry Masur, Irini Sereti.   

Abstract

Idiopathic CD4(+) lymphocytopenia (ICL) is a rare non-HIV-related syndrome with unclear natural history and prognosis. This prospective natural history cohort study describes the clinical course, CD4 T lymphocyte kinetics, outcome, and prognostic factors of ICL. Thirty-nine patients (17 men, 22 women) 25 to 85 years old with ICL were evaluated between 1992 and 2006, and 36 were followed for a median of 49.5 months. Cryptococcal and nontuberculous mycobacterial infections were the major presenting opportunistic infections. Seven patients presented with no infection. In 32, CD4 T-cell counts remained less than 300/mm(3) throughout the study period and in 7 normalized after an average of 31 months. Overall, 15 (41.6%) developed an opportunistic infection in follow-up, 5 (13.8%) of which were "AIDS-defining clinical conditions," and 4 (11.1%) developed autoimmune diseases. Seven patients died, 4 from ICL-related opportunistic infections, within 42 months after diagnosis. Immunologic analyses revealed increased activation and turnover in CD4 but not CD8 T lymphocytes. CD8 T lymphocytopenia (< 180/mm(3)) and the degree of CD4 T cell activation (measured by HLA-DR expression) at presentation were associated with adverse outcome (opportunistic infection-related death; P = .003 and .02, respectively).

Entities:  

Mesh:

Year:  2008        PMID: 18456875      PMCID: PMC2442741          DOI: 10.1182/blood-2007-12-127878

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.

Authors:  R A Lempicki; J A Kovacs; M W Baseler; J W Adelsberger; R L Dewar; V Natarajan; M C Bosche; J A Metcalf; R A Stevens; L A Lambert; W G Alvord; M A Polis; R T Davey; D S Dimitrov; H C Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Successful IL-2 therapy for relapsing herpes zoster infection in a patient with idiopathic CD4+ T lymphocytopenia.

Authors:  K Warnatz; R Draeger; M Schlesier; H H Peter
Journal:  Immunobiology       Date:  2000-08       Impact factor: 3.144

3.  Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7.

Authors:  Angela Malaspina; Susan Moir; Doreen G Chaitt; Catherine A Rehm; Shyam Kottilil; Judith Falloon; Anthony S Fauci
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

4.  Cryptococcosis and idiopathic CD4 lymphocytopenia.

Authors:  Dimitrios I Zonios; Judith Falloon; Chiung-Yu Huang; Doreen Chaitt; John E Bennett
Journal:  Medicine (Baltimore)       Date:  2007-03       Impact factor: 1.889

Review 5.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

Authors:  M D Hazenberg; D Hamann; H Schuitemaker; F Miedema
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

6.  A potential role for interleukin-7 in T-cell homeostasis.

Authors:  T J Fry; E Connick; J Falloon; M M Lederman; D J Liewehr; J Spritzler; S M Steinberg; L V Wood; R Yarchoan; J Zuckerman; A Landay; C L Mackall
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells.

Authors:  Irini Sereti; Hector Martinez-Wilson; Julia A Metcalf; Michael W Baseler; Claire W Hallahan; Barbara Hahn; Richard L Hengel; Richard T Davey; Joseph A Kovacs; H Clifford Lane
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

8.  Detection of CD4(+) T-cell antibodies in a patient with idiopathic CD4 T lymphocytopenia and cryptococcal meningitis.

Authors:  Rachel B Salit; Kim G Hankey; Rosemary Yi; Aaron P Rapoport; Dean L Mann
Journal:  Br J Haematol       Date:  2007-10       Impact factor: 6.998

9.  Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.

Authors:  Kara B Anthony; Christian Yoder; Julia A Metcalf; Rebecca DerSimonian; Jan M Orenstein; Randy A Stevens; Judy Falloon; Michael A Polis; H Clifford Lane; Irini Sereti
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

10.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

View more
  80 in total

1.  MonoMAC versus idiopathic CD4+ lymphocytopenia. Comment to Haematologica. 2011;96(8):1221-5.

Authors:  Vicki H Chu; Jonathan L Curry; M Tarek Elghetany; Choladda V Curry
Journal:  Haematologica       Date:  2012-04       Impact factor: 9.941

Review 2.  Consequences of a mutation in the UNC119 gene for T cell function in idiopathic CD4 lymphopenia.

Authors:  Magdalena M Gorska; Rafeul Alam
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

3.  Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.

Authors:  Ivan Jelcic; Benoit Combaluzier; Ilijas Jelcic; Wolfgang Faigle; Luzia Senn; Brenda J Reinhart; Luisa Ströh; Roger M Nitsch; Thilo Stehle; Mireia Sospedra; Jan Grimm; Roland Martin
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

4.  Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.

Authors:  Jessie Grewal; Poorvi Dalal; Michelle Bowman; Behiye Kaya; José Javier Otero; Jaime Imitola
Journal:  J Neurovirol       Date:  2016-06-06       Impact factor: 2.643

5.  Idiopathic CD4 lymphocytopenia: Pathogenesis, etiologies, clinical presentations and treatment strategies.

Authors:  Hale Yarmohammadi; Charlotte Cunningham-Rundles
Journal:  Ann Allergy Asthma Immunol       Date:  2017-10       Impact factor: 6.347

6.  CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.

Authors:  Mahboubeh Rahmani; Brooke M Fortin; Nancy Berliner; Nicolas Issa; Donna Neuberg; Richard M Kaufman; John M Gansner
Journal:  Transfusion       Date:  2019-02-12       Impact factor: 3.157

Review 7.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

8.  Expanding mechanistic insights into the pathogenesis of idiopathic CD4+ T cell lymphocytopenia.

Authors:  Jose S Campos; Sarah E Henrickson; Roshini S Abraham
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

9.  Case study documenting the diagnosis of idiopathic CD4+ Lymphocytopenia in a patient with atypical fungal infection (disseminated blastomycosis) by FNA of adrenal mass.

Authors:  Richard H Siderits; Osman Ouattara; Alan Marcus; Hong Guang Gao; Hong Bing Deng; Janusz Godyn
Journal:  Cytojournal       Date:  2010-08-05       Impact factor: 2.091

10.  Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.

Authors:  Christos Vaklavas; Elsa P Sotelo-Rafiq; Jordan Lovy; Miguel A Escobar; Apostolia M Tsimberidou
Journal:  Virol J       Date:  2010-09-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.